Diagnosis using Metatron Hunter

Chronic forms of cerebrovascular disease are becoming increasingly important in the structure of cerebrovascular disorders. Among these, circulatory encephalopathy (DE) accounts for the largest proportion. While the clinical presentation of this disease is well-studied, from a case-medical perspective, questions regarding structural changes in brain detection, identification of clinical and instrumental similarities, and early definition of optimal treatment strategies are becoming increasingly urgent.

We can use the Metatron system with a 4.9 GHz generator frequency and Metatron Hunter software to diagnose DE.

The clinical presentation of DE has a progressive process. Analysis of NLS-research results confirms that in the first stage of the disease, there are no characteristic changes in the brain, and no obvious neurological syndromes develop; subjective disturbances accompanied by mild neurosymptoms are dominant. The second stage of DE allows us to identify certain prevalent neurological syndromes—incoordination, pyramidal and dystonia—manifested as single or multiple gliomas without a tendency to co-occur, which is a significant reason for reduced professional and social adaptation in patients. Based on data from NLS-research and REA, in stage III of DE, the number of complaints decreases significantly, but neurological disorders become more prominent, presenting as very obvious and significant neurological syndromes combined with marked brain structural changes.

The diagnosis of DE is complex and involves neurovisual methods, and we believe one of the most informative and prospective approaches is NLS imaging with REA. Detecting and evaluating nested and diffuse NLS changes in brain tissue within the context of clinical and subclinical neurological and neuropsychological data creates conditions for early diagnosis of progressive forms of DE and for targeted, aggressive treatment to prevent further brain damage.

The diagnostic value of the Metatron Hunter is substantial and significant for medical practice.